Effect of serum components on biofilm formation by Aspergillus fumigatus and other Aspergillus species

Japanese Journal of Infectious Diseases

Volumn 67, Issue 3, 2014, Pages 172-179

  Wuren, Tuya ^a,b   Toyotome, Takahito ^a   Yamaguchi, Masashi ^a   Takahashi Nakaguchi, Azusa ^a   Muraosa, Yasunori ^a   Yahiro, Maki ^a   Wang, Dan Ni ^a   Watanabe, Akira ^a,c   Taguchi, Hideaki ^a   Kamei, Katsuhiko ^a,c  

^a CHIBA UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Biofilm; Bovine serum albumin (BSA); Fetuin A; Serum; Spergillus

Indexed keywords

AMPHOTERICIN B; BOVINE SERUM ALBUMIN; DIMETHYL SULFOXIDE; FETUIN A; MICAFUNGIN; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS; ASPERGILLUS CONIDIA; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULAN; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BIOFILM; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; EXTRACELLULAR MATRIX; FETAL CALF SERUM; FUNGAL CELL WALL; FUNGAL STRAIN; FUNGUS GROWTH; HYPHEN WALL STAINING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENICITY; SCANNING ELECTRON MICROSCOPY; STAINING; TRANSMISSION ELECTRON MICROSCOPY; VIRULENCE; XTT ASSAY; CHEMISTRY; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; SERUM;

ALPHA-2-HS-GLYCOPROTEIN; ANTIFUNGAL AGENTS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BIOFILMS; DRUG RESISTANCE, FUNGAL; MICROBIAL SENSITIVITY TESTS; SERUM; SERUM ALBUMIN, BOVINE;

EID: 84901374378     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.67.172     Document Type: Article

References (29)

1. Suzuki Y, Kume H, Togano T, et al. Epidemiology of visceral mycoses in autopsy cases in Japan: the data from 1989 to 2009 in the Annual of Pathological Autopsy Cases in Japan. Med Mycol. 2013;51:522-6.
2. Perkhofer S, Trappl K, Striessnig B, et al. Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. Med Mycol. 2011;49:157-66.
3. Beauvais A, Schmidt C, Guadagnini S, et al. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol. 2007;9:1588-600.
4. Seidler MJ, Salvenmoser S, Muäller FM. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother. 2008;52:4130-6.
5. Loussert C, Schmitt C, Prevost MC, et al. In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol. 2010;12:405-10.
6. Toyotome T, Yamaguchi M, Iwasaki A, et al. Fetuin A, a serum component, promotes growth and biofilm formation by Aspergillus fumigatus. Int J Med Microbiol. 2012;302:108-16.
7. Meletiadis J, Mouton JW, Meis JF, et al. (2001): Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol. 2001;39:3402-8.
8. Yamaguchi M, Okada H, Namiki Y. Smart specimen preparation for freeze-substitution and serial ultrathin sectioning of yeast cells. J Electron Microsc. 2009;58:261-6.
9. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard M38-A2. 28. 2nd ed. Wayne (PA): CLSI; 2008.
10. Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494-500.
11. Liu W, Li L, Sun Y, et al. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro. Antimicrob Agents Chemother. 2012;56:6414-6.
12. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.
13. Tobudic S, Kratzer C, Lassnigg A, et al. In vitro activity of antifungal combination against Candida albicans biofilms. J Antimicrob Chemother. 2010;65:271-4.
14. Gifford AH, Klippenstein JR, Moore MM. Serum stimulates growth of and proteinase secretion by Aspergillus fumigatus. Infect Immun. 2002;70:19-26.
15. Jahnen-Dechent W, Heiss A, Schäafer C, et al. Fetuin-A regulation of calcified matrix metabolism. Circ Res. 2011;108:1494-509.
16. Goustin AS, Abou-Samra AB. The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance. Cell Signal. 2011;23:980-90.
17. Manolakis AC, Tiaka EK, Kapsoritakis AN, et al. Increased fetuin A levels in Helicobacter pylori infection: a missing link between H. pylori and insulin resistance? Diabetologia. 2011;54:472-4.
18. Rajendran R, Williams C, Lappin DF, et al. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot Cell. 2013;12:420-9.
19. Rodrfáguez-Martfánez JM, Pascual A. Activity of antimicrobial agents on bacterial biofilms. Enferm Infecc Microbiol Clin. 2008;26:107-14.
20. Inãigo M, Pemaán J, Del Pozo, JL. Antifungal activity against Candida biofilms. Int J Artif Organs. 2008;35:780-91.
21. Cueállar-Cruz M, Vega-Gonzaález A, Mendoza-Novelo B, et al. The effect of biomaterials and antifungals on biofilm formation by Candida species: a review. Eur J Clin Microbiol Infect Dis. 2012;31:2513-27.
22. Montejo M, Quindoás G. Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis. Enferm Infecc Microbiol Clin. 2011;29 Suppl 2:15-22.
23. KucharfákovaáS, Sharma N, Spriet I, et al. Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model. Antimicrob Agents Chemother. 2013;57:2365-8.
24. Mowat E, Butcher J, Lang S, et al. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol. 2007;56:1205-12.
25. Mowat E, Lang S, Williams C, et al. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. J Antimicrob Chemother. 2008;62:1281-4.
26. Meletiadis J, Stergiopoulou T, O'Shaughnessy EM, et al. Concentration- dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model. Antimicrob Agents Chemother. 2007;51:2053-64.
27. Spreghini E, Orlando F, Santinelli A, et al. Anidulafungin in combination with amphotericin B against Aspergillus fumigatus. Antimicrob Agents Chemother. 2009;53:4035-9.
28. Marr KA, Schlamm H, Rottinghaus ST, et al. A randomized, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis. Poster LB2812. 22nd ECCMID; 2012; London, UK. Available at http://registration.akm.ch/einsicht.php?XNABSTRACT_ID=151894&XNSPRACHE_ID=2&XNKONGRESS_ID=161&XNMASKEN_ID=900
29. Kamei K, Watanabe A. Aspergillus mycotoxins and their effect on the host. Med Mycol. 2005;43 Suppl 1:95-9.